{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:32:15Z","timestamp":1765233135622},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1001\/jamapsychiatry.2021.1715","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T15:01:03Z","timestamp":1626274863000},"page":"1071","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy"],"prefix":"10.1001","volume":"78","author":[{"given":"Sarah H.","family":"Heil","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"},{"name":"Department of Psychological Science, University of Vermont, Burlington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi S.","family":"Melbostad","sequence":"additional","affiliation":[{"name":"Department of Psychological Science, University of Vermont, Burlington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis K.","family":"Matusiewicz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina N.","family":"Rey","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"},{"name":"University of Nebraska Medical Center, Omaha"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Badger","sequence":"additional","affiliation":[{"name":"Department of Medical Biostatistics, University of Vermont, Burlington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald S.","family":"Shepard","sequence":"additional","affiliation":[{"name":"Brandeis University, Waltham, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey C.","family":"Sigmon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"},{"name":"Department of Psychological Science, University of Vermont, Burlington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren K.","family":"MacAfee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Vermont, Burlington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"},{"name":"Department of Psychological Science, University of Vermont, Burlington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"yoi210040r1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017.","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"yoi210040r2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jamapediatrics.2019.4791","article-title":"Neonatal abstinence syndrome incidence and health care costs in the United States, 2016.","volume":"174","author":"Strahan","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"3","key":"yoi210040r3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0562","article-title":"Educational disabilities among children born with neonatal abstinence syndrome.","volume":"142","author":"Fill","year":"2018","journal-title":"Pediatrics"},{"issue":"13","key":"yoi210040r4","first-page":"S264","article-title":"The opioid epidemic, neonatal abstinence syndrome, and estimated costs for special education services.","volume":"25","author":"Morgan","year":"2019","journal-title":"Am J Manag Care"},{"issue":"6","key":"yoi210040r5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/DBP.0000000000000679","article-title":"Early intervention referral and enrollment among infants with neonatal abstinence syndrome.","volume":"40","author":"Peacock-Chambers","year":"2019","journal-title":"J Dev Behav Pediatr"},{"issue":"9","key":"yoi210040r6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.15585\/mmwr.mm6609a2","article-title":"CDC Grand Rounds: Public health strategies to prevent neonatal abstinence syndrome.","volume":"66","author":"Ko","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"yoi210040r7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4070","article-title":"COMMITTEE ON SUBSTANCE USE AND PREVENTION. A public health response to opioid use in pregnancy.","volume":"139","author":"Patrick","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"yoi210040r8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women.","volume":"40","author":"Heil","year":"2011","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"yoi210040r9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1089\/jwh.2017.6564","article-title":"Reproductive health knowledge, attitudes, and behaviors among women enrolled in medication-assisted treatment for opioid use disorder.","volume":"27","author":"Meschke","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"yoi210040r10","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1097\/JPN.0000000000000401","article-title":"Barriers to reproductive healthcare for women with opioid use disorder.","volume":"33","author":"Smith","year":"2019","journal-title":"J Perinat Neonatal Nurs"},{"key":"yoi210040r11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","article-title":"Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review.","volume":"80","author":"Terplan","year":"2015","journal-title":"Prev Med"},{"issue":"11","key":"yoi210040r12","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/10826084.2016.1188944","article-title":"Family planning in substance use disorder treatment centers: opportunities and challenges.","volume":"51","author":"Robinowitz","year":"2016","journal-title":"Subst Use Misuse"},{"issue":"1","key":"yoi210040r13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/10826084.2019.1656255","article-title":"Substance use treatment patient and provider perspectives on accessing sexual and reproductive health services: barriers, facilitators, and the need for integration of care.","volume":"55","author":"MacAfee","year":"2020","journal-title":"Subst Use Misuse"},{"key":"yoi210040r14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ypmed.2016.06.023","article-title":"Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy.","volume":"92","author":"Heil","year":"2016","journal-title":"Prev Med"},{"issue":"4","key":"yoi210040r18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/AOG.0b013e3181875ec5","article-title":"Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation.","volume":"112","author":"Nelson","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"yoi210040r19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02893805","article-title":"Reliability of the timeline follow-back sexual behavior interview.","volume":"20","author":"Wein Hardt","year":"1998","journal-title":"Ann Behav Med"},{"issue":"2","key":"yoi210040r20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1023\/A:1014888905882","article-title":"Effects of a detailed sexual behavior interview on perceived risk of HIV infection: preliminary experimental analysis in a high risk sample.","volume":"25","author":"Weinhardt","year":"2002","journal-title":"J Behav Med"},{"issue":"2","key":"yoi210040r21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.contraception.2009.02.009","article-title":"Social desirability bias in family planning studies: a neglected problem.","volume":"80","author":"Stuart","year":"2009","journal-title":"Contraception"},{"issue":"6","key":"yoi210040r22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.contraception.2017.08.013","article-title":"Measuring oral contraceptive adherence using self-report versus pharmacy claims data.","volume":"96","author":"Nelson","year":"2017","journal-title":"Contraception"},{"issue":"4","key":"yoi210040r24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.contraception.2008.05.007","article-title":"Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth.","volume":"78","author":"Vaughan","year":"2008","journal-title":"Contraception"},{"key":"yoi210040r25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2046-4053-3-47","article-title":"Micro-costing studies in the health and medical literature: protocol for a systematic review.","volume":"3","author":"Xu","year":"2014","journal-title":"Syst Rev"},{"issue":"1","key":"yoi210040r26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.contraception.2008.08.003","article-title":"Cost effectiveness of contraceptives in the United States.","volume":"79","author":"Trussell","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"yoi210040r27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.contraception.2014.08.011","article-title":"Achieving cost-neutrality with long-acting reversible contraceptive methods.","volume":"91","author":"Trussell","year":"2015","journal-title":"Contraception"},{"issue":"7168","key":"yoi210040r28","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat.","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"issue":"2","key":"yoi210040r29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.contraception.2012.07.016","article-title":"Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception.","volume":"87","author":"Trussell","year":"2013","journal-title":"Contraception"},{"key":"yoi210040r30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jpeds.2018.08.032","article-title":"A longitudinal healthcare use profile of children with a history of neonatal abstinence syndrome.","volume":"204","author":"Liu","year":"2019","journal-title":"J Pediatr"},{"issue":"6","key":"yoi210040r35","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/add.2012.107.issue-6","article-title":"Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception?","volume":"107","author":"Lucke","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"yoi210040r36","first-page":"3","article-title":"Some lawmakers continue to promote contraceptive use in return for welfare.","volume":"6","author":"Gold","year":"1995","journal-title":"State Reprod Health Monit"},{"issue":"2","key":"yoi210040r38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/add.2006.101.issue-2","article-title":"A meta-analysis of voucher-based reinforcement therapy for substance use disorders.","volume":"101","author":"Lussier","year":"2006","journal-title":"Addiction"},{"key":"yoi210040r23","first-page":"95","volume-title":"Contraceptive Technology","author":"Trussell","year":"2018"},{"key":"yoi210040r15","unstructured":"World Health Organization. John Hopkins Bloomberg School of Public Health. Center for Communication Programs. Decision-making tool for family planning clients and providers. Accessed March 1, 2021. https:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/9241593229index\/en\/"},{"key":"yoi210040r16","unstructured":"American Society of Addiction Medicine. Public policy statement on substance use, misuse, and use disorders during and following pregnancy, with an emphasis on opioids. Accessed March 1, 2021. https:\/\/www.asam.org\/docs\/default-source\/public-policy-statements\/substance-use-misuse-and-use-disorders-during-and-following-pregnancy.pdf?sfvrsn=644978c2_4"},{"key":"yoi210040r17","unstructured":"World Health Organization. Decision-making tool for family planning clients and providers: technical adaptation guide. Accessed March 1, 2021. https:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/Technical_adaptation_guide.pdf"},{"key":"yoi210040r31","unstructured":"Centers for Medicare & Medicaid Services. National Health Expenditure Data. Accessed May 1, 2021. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/NationalHealthExpendData\/"},{"key":"yoi210040r32","unstructured":"Lino? M, Kuczynski? K, Rodriguez? N, Schap? T. Expenditures on Children by Families, 2015. Accessed May 1, 2021. https:\/\/fns-prod.azureedge.net\/sites\/default\/files\/crc2015_March2017.pdf"},{"key":"yoi210040r33","unstructured":"Child Care Resource. Chittenden County Child Care Statistics. Accessed May 1, 2021. https:\/\/www.childcareresource.org\/for-everyone\/chittenden-county-child-care-statistics\/"},{"key":"yoi210040r34","unstructured":"Kolbe? T, Kieran? K. Study of Vermont State Funding for Special Education: Executive Summary. Accessed March 1, 2021. https:\/\/legislature.vermont.gov\/assets\/Legislative-Reports\/edu-legislative-report-special-education-funding-study-executive-summary-and-full-report.pdf"},{"key":"yoi210040r37","unstructured":"Project Prevention. http:\/\/www.projectprevention.org. Accessed March 1, 2021."},{"key":"yoi210040r39","unstructured":"Substance Abuse and Mental Health Data Archive. Treatment episode data set: admissions 2018 (TEDS-A-2018).Accessed March 1, 2021. https:\/\/www.datafiles.samhsa.gov\/study\/treatment-episode-data-set-admissions-teds-2018-nid19019"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2781882\/jamapsychiatry_heil_2021_oi_210040_1632334570.44887.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T21:54:43Z","timestamp":1633816483000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2781882"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.1715","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}